Divi’s Laboratories recorded a decent set of numbers for the September quarter, with both profit and revenue rising year-on-year and beating Street estimates. The pharma major also recorded a foreign exchange gain of ₹63 crore during the quarter.
Divi’s Laboratories recorded a decent set of numbers for the September quarter, with both profit and revenue rising year-on-year and beating Street estimates. The pharma major also recorded a foreign exchange gain of ₹63 crore during the quarter.